In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives

Antiviral Research

Volumn 94, Issue 3, 2012, Pages 217-224

  Zu, Mian ^a   Yang, Fan ^a   Zhou, Weiling ^a   Liu, Ailin ^a,b   Du, Guanhua ^a,b   Zheng, Lishu ^c  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b Beijing Key Laboratory of Drug Target Research and Drug Screening   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Anti inflammatory; Antiviral; Influenza virus; Theaflavin derivatives

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; HEMAGGLUTININ; INTERLEUKIN 6; MESSENGER RNA; RIBAVIRIN; RIBONUCLEOPROTEIN; SIALIDASE; THEAFLAVIN; THEAFLAVIN 3,3' GALLATE; THEAFLAVINE 3 GALLATE; THEAFLAVINE 3' GALLATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOPLASM; DRUG CYTOTOXICITY; GENE EXPRESSION; GENE REPLICATION; HEMAGGLUTINATION INHIBITION TEST; HIGH THROUGHPUT SCREENING; IC 50; IN VITRO STUDY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TISSUE INJURY; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BIFLAVONOIDS; CAMELLIA; CATECHIN; CELL LINE; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INHIBITORY CONCENTRATION 50; INTERLEUKIN-6; MICROBIAL SENSITIVITY TESTS; NEURAMINIDASE; PLANT EXTRACTS; REAL-TIME POLYMERASE CHAIN REACTION;

CAMELLIA SINENSIS; ORTHOMYXOVIRIDAE;

EID: 84860991887     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.04.001     Document Type: Article

References (34)

1. Beigel J.H., Farrar J., Han A.M., Hayden F.G., Hyer R., de Jong M.D., Lochindarat S., Nguyen T.K., Nguyen T.H., Tran T.H., Nicoll A., Touch S., Yuen K.Y. Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5, 2005. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 2005, 353:1374-1385.
2. Chen D.Y., Shien J.H., Tiley L., Chiou S.S., Wang S.Y., Chang T.J., Lee Y.J., Chan K.W., Hsu W.L. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem. 2010, 119:1346-1351.
3. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12:1203-1207.
4. Dolin R. Resistance to neuraminidase inhibitors. Clin. Infect. Dis. 2011, 52:438-439.
5. Fiers W., De Filette M., Birkett A., Neirynck S., Min Jou W. A " universal" human influenza A vaccine. Virus Res. 2004, 103:173-176.
6. Geiler J., Michaelis M., Naczk P., Leutz A., Langer K., Doerr H.W., Cinatl J. N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem. Pharmacol. 2010, 79:413-420.
7. Grienke U., Schmidtke M., von Grafenstein S., Kirchmair J., Liedl K.R., Rollinger J.M. Influenza neuraminidase: a druggable target for natural products. Nat. Prod. Rep. 2012, 29:11-36.
8. Hajhashemi V., Sajjadi S.E., Zomorodkia M. Antinociceptive and anti-inflammatory activities of Bunium persicum essential oil, hydroalcoholic and polyphenolic extracts in animal models. Pharm. Biol. 2011, 49:146-151.
9. Henning S.M., Aronson W., Niu Y., Conde F., Lee N.H., Seeram N.P., Lee R.P., Lu J., Harris D.M., Moro A., Hong J., Pak-Shan L., Barnard R.J., Ziaee H.G., Csathy G., Go V.L., Wang H., Heber D. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J. Nutr. 2006, 136:1839-1843.
10. Hurt, A.C., Deng, Y.M., Ernest, J., Caldwell, N., Leang, L., Iannello, P., Komadina, N., Shaw, R., Smith, D., Dwyer, D.E., Tramontana, A.R., Lin, R.T., Freeman, K., Kelso, A., Barr, I.G., 2011. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010. Euro Surveill. 16, pii: 19770.
11. Josset L., Frobert E., Rosa-Calatrava M. Influenza A replication and host nuclear compartments: many changes and many questions. J. Clin. Virol. 2008, 43:381-390.
12. Karlas A., Machuy N., Shin Y., Pleissner K.P., Artarini A., Heuer D., Becker D., Khalil H., Ogilvie L.A., Hess S., Mäurer A.P., Müller E., Wolff T., Rudel T., Meyer T.F. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463:818-822.
13. Kash J.C., Tumpey T.M., Proll S.C., Carter V., Perwitasari O., Thomas M.J., Basler C.F., Palese P., Taubenberger J.K., García-Sastre A., Swayne D.E., Katze M.G. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006, 443:578-581.
14. Knobil K., Choi A.M., Weigand G.W., Jacoby D.B. Role of oxidants in influenza virus-induced gene expression. Am. J. Physiol. 1998, 274:L134-L142.
15. Kuzuhara, T., Iwai, Y., Takahashi, H., Hatakeyama, D., Echigo, N., 2009. Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerase. PLoS Curr. 1, RRN1052.
16. Kwon H.J., Kim H.H., Yoon S.Y., Ryu Y.B., Chang J.S., Cho K.O., Rho M.C., Park S.J., Lee W.S. In vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination. Virol. J. 2010, 7:307.
17. Liu A.L., Liu B., Qin H.L., Lee S.M., Wang Y.T., Du G.H. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 2008, 74:847-851.
18. Liu A.L., Wang H.D., Lee S.M., Wang Y.T., Du G.H. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg. Med. Chem. 2008, 16:7141-7147.
19. Liu A.L., Yang F., Zu M., Zhou D., Lee S.M., Wang Y.T., Du G.H. In vitro anti-influenza viral activities of stilbenoids from the lianas of Gnetum pendulum. Planta Med. 2010, 76:1874-1876.
20. Longtin J., Patel S., Eshaghi A., Lombos E., Higgins R., Alexander D., Olsha R., Doyle J., Tran D., Sarabia A., Lee C., Bastien N., Li Y., Low D., Boivin G., Gubbay J. Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario. Can. J. Clin. Virol. 2011, 50:257-261.
21. Manco S., Hernon F., Yesilkaya H., Paton J.C., Andrew P.W., Kadioglu A. Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect. Immun. 2006, 74:4014-4020.
22. Min J.Y., Subbarao K. Cellular targets for influenza drugs. Nat. Biotechnol. 2010, 28:239-240.
23. Miller, M., Viboud, C., Simonsen, L., Olson, D.R., Russell, C., 2009. Mortality and morbidity burden associated with A/H1N1pdm influenza virus: Who is likely to be infected, experience clinical symptoms, or die from the H1N1pdm 2009 pandemic virus ? PLoS Curr. 1, RRN1013.
24. Nakayama M., Suzuki K., Toda M., Okubo S., Hara Y., Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 1993, 21:289-299.
25. Oda T., Akaike T., Hamamoto T., Suzuki F., Hirano T., Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 1989, 244:974-976.
26. Pielak R.M., Chou J.J. Flu channel drug resistance: a tale of two sites. Protein Cell 2010, 1:246-258.
27. Potier M., Mameli L., Bélisle M., Dallaire L., Melançon S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 1979, 94:287-296.
28. Ramirez-Gonzalez J.E., Gonzalez-Duran E., Alcantara-Perez P., Wong-Arambula C., Olivera-Diaz H., Cortez-Ortiz I., Barrera-Badillo G., Nguyen H., Gubareva L., Lopez-Martinez I., Díaz-Quiñonez J.A., Lezana-Fernández M.A., Gatell-Ramírez H.L., Cordova Villalobos J.A., Hernández-Avila M., Alpuche-Aranda C. Oseltamivir-resistant pandemic (H1N1) 2009 virus. Mexico Emerg. Infect. Dis. 2011, 17:283-286.
29. Robert E.A.H. The phenolic substance of manufactured tea. J. Sci. Food Agric. 1958, 9:212-216.
30. Schmidtke M., Schnittler U., Jahn B., Dahse H., Stelzner A. A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. J. Virol. Methods 2001, 95:133-143.
31. Song J.M., Lee K.H., Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005, 68:66-74.
32. Szliszka E., Zydowicz G., Janoszka B., Dobosz C., Kowalczyk-Ziomek G., Krol W. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis. Int. J. Oncol. 2011, 38:941-953.
33. Taubenberger J.K., Reid A.H., Janczewski T.A., Fanning T.G. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356:1829-1839.
34. Yook H.S., Kim K.H., Park J.E., Shin H.J. Antioxidative and antiviral properties of flowering cherry fruits (Prunus serrulata L. var. spontanea). Am. J. Chin. Med. 2010, 38:937-948.